88% of EYLEA HD patients had a last assigned dosing interval of ≥12 weeks at week 156, while sustaining visual…
Garden City, New York--(Newsfile Corp. - October 18, 2024) - Silberstein, Awad & Miklos, P.C. (ASK4SAM), a leading personal injury…
SAN DIEGO, Oct. 18, 2024 /PRNewswire/ -- Cooler Heads, a leader in scalp cooling technology, celebrates a groundbreaking update in…
The “Powering Milwaukee Forward” initiative will fund 10 Milwaukee organizations to increase access to basic needs and maternal healthcare in…
LORTON, Va., Oct. 18, 2024 /PRNewswire/ -- Olight, a brand committed to becoming a global leader in mid-to-high-end flashlights, introduced…
Event to Raise Funds for Women in the Underserved Community in Los Angeles Struggling to Afford Cancer Treatment LOS ANGELES,…
HOUSTON, Oct. 18, 2024 (GLOBE NEWSWIRE) -- FibroBiologics, Inc., (Nasdaq: FBLG) (“FibroBiologics”) and Charles River Laboratories (“Charles River”), a leading…
Richland WA N, Oct. 18, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. Certifies new clinic for IsoPet…
RIYADH, Saudi Arabia, Oct. 18, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) is contributing to…
If approved, patients in Europe with stage II or III HR+/HER2- early breast cancer (EBC) at high risk of recurrence,…